Ritsuko Kohno1, Barry L S Detloff1, Lin Yee Chen1, Faye L Norby2, David G Benditt1. 1. Cardiac Arrhythmia Center, Cardiovascular Division, University of Minnesota, Minneapolis, Minnesota. 2. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: Head-up tilt (HUT) is widely used for diagnostic evaluation of patients with suspected vasovagal syncope (VVS), but also offers an opportunity to study VVS pathophysiology. In this regard, it is known that plasma epinephrine (Epi) levels and Epi/norepinephrine (NE) ratio are markedly increased from baseline at the time of HUT-induced VVS. However, whether these changes contribute to VVS susceptibility remains uncertain. OBJECTIVE: We hypothesized that if catecholamines contributed to VVS directly, then a greater increase of plasma Epi and Epi/NE ratio early during HUT would be associated with shorter time to syncope. METHODS: The patient population comprised 33 individuals (14 men, 43 ± 2 years) with suspected VVS in whom 70° HUT reproduced symptoms. Arterial Epi and NE concentrations were collected at baseline (supine) and 2 minutes of HUT. Linear, exponential, and multiple regression were used to access the association between changing catecholamine levels and time to syncope. RESULTS: Mean ± SD time to positive HUT was 11 (7.6) minutes. Higher plasma Epi levels (pg/mL) both at baseline and at 2 minutes upright correlated with shorter time to syncope (baseline, R = -0.35, P = 0.048; and 2 minutes, R = -0.58, P = 0.001). Similarly, a greater Epi/NE ratio at 2 minutes head-up correlated with earlier time to syncope (R = -0.49, P = 0.007). These relationships remained significant after adjusting for age and sex (P = 0.006 and 0.02, respectively). CONCLUSION: Greater Epi levels and Epi/NE ratio early during HUT were associated with shorter time to VVS, suggesting a possible contribution to VVS susceptibility.
BACKGROUND: Head-up tilt (HUT) is widely used for diagnostic evaluation of patients with suspected vasovagal syncope (VVS), but also offers an opportunity to study VVS pathophysiology. In this regard, it is known that plasma epinephrine (Epi) levels and Epi/norepinephrine (NE) ratio are markedly increased from baseline at the time of HUT-induced VVS. However, whether these changes contribute to VVS susceptibility remains uncertain. OBJECTIVE: We hypothesized that if catecholamines contributed to VVS directly, then a greater increase of plasma Epi and Epi/NE ratio early during HUT would be associated with shorter time to syncope. METHODS: The patient population comprised 33 individuals (14 men, 43 ± 2 years) with suspected VVS in whom 70° HUT reproduced symptoms. Arterial Epi and NE concentrations were collected at baseline (supine) and 2 minutes of HUT. Linear, exponential, and multiple regression were used to access the association between changing catecholamine levels and time to syncope. RESULTS: Mean ± SD time to positive HUT was 11 (7.6) minutes. Higher plasma Epi levels (pg/mL) both at baseline and at 2 minutes upright correlated with shorter time to syncope (baseline, R = -0.35, P = 0.048; and 2 minutes, R = -0.58, P = 0.001). Similarly, a greater Epi/NE ratio at 2 minutes head-up correlated with earlier time to syncope (R = -0.49, P = 0.007). These relationships remained significant after adjusting for age and sex (P = 0.006 and 0.02, respectively). CONCLUSION: Greater Epi levels and Epi/NE ratio early during HUT were associated with shorter time to VVS, suggesting a possible contribution to VVS susceptibility.
Authors: David G Benditt; Barry L S Detloff; Wayne O Adkisson; Fei Lu; Scott Sakaguchi; Stefanie Schussler; Erin Austin; Lin Yee Chen Journal: Heart Rhythm Date: 2012-08-01 Impact factor: 6.343
Authors: Ashish Chaddha; Martina Rafanelli; Michele Brignole; Richard Sutton; Kevin E Wenzke; Stephen L Wasmund; Richard L Page; Mohamed H Hamdan Journal: Clin Auton Res Date: 2016-06-20 Impact factor: 4.435
Authors: Robert Sheldon; Stuart Connolly; Sarah Rose; Thomas Klingenheben; Andrew Krahn; Carlos Morillo; Mario Talajic; Teresa Ku; Fetnat Fouad-Tarazi; Debbie Ritchie; Mary-Lou Koshman Journal: Circulation Date: 2006-02-27 Impact factor: 29.690
Authors: David S Goldstein; Courtney Holmes; Steven M Frank; Mohammad Naqibuddin; Raghuveer Dendi; Sally Snader; Hugh Calkins Journal: Am J Cardiol Date: 2003-01-01 Impact factor: 2.778
Authors: Satish R Raj; Peter D Faris; Lisa Semeniuk; Braden Manns; Andrew D Krahn; Carlos A Morillo; David G Benditt; Robert S Sheldon Journal: Am Heart J Date: 2016-01-25 Impact factor: 4.749
Authors: Parisa Torabi; Fabrizio Ricci; Viktor Hamrefors; Olle Melander; Richard Sutton; David G Benditt; Artur Fedorowski Journal: J Am Heart Assoc Date: 2019-06-18 Impact factor: 5.501